Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Theratechnologies Inc (THTX)

Theratechnologies Inc (THTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,431
  • Shares Outstanding, K 24,202
  • Annual Sales, $ 81,760 K
  • Annual Income, $ -23,960 K
  • 60-Month Beta 1.34
  • Price/Sales 0.40
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade THTX with:

Options Overview Details

View History
  • Implied Volatility 374.02% ( +180.10%)
  • Historical Volatility 69.84%
  • IV Percentile 76%
  • IV Rank 38.53%
  • IV High 878.27% on 08/08/23
  • IV Low 57.94% on 03/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 374
  • Open Int (30-Day) 385

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +249,850.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2200 +13.11%
on 03/25/24
1.7000 -18.82%
on 04/01/24
+0.1100 (+8.66%)
since 03/22/24
3-Month
1.1600 +18.97%
on 03/08/24
1.7700 -22.03%
on 01/30/24
-0.3400 (-19.77%)
since 01/23/24
52-Week
0.8800 +56.82%
on 11/01/23
4.3000 -67.91%
on 05/04/23
-2.4596 (-64.06%)
since 04/21/23

Most Recent Stories

More News
Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

/CNW/ - Theratechnologies Inc. ("Theratechnologies" or the "Company") (Nasdaq: THTX) (TSX: TH), a biopharmaceutical company focused on the development and...

THTX : 1.3800 (+2.99%)
TH.TO : 1.89 (+2.16%)
Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

/PRNewswire/ - Paul Lévesque, President and Chief Executive Officer, Hamilton Thorne Ltd. ("Theratechnologies", the "Company", or "we") (TSX: TH) shares his...

THTX : 1.3800 (+2.99%)
TH.TO : 1.89 (+2.16%)
Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

/CNW/ - Paul Lévesque, President and Chief Executive Officer, Hamilton Thorne Ltd. ("Theratechnologies", the "Company", or "we") (TSX: TH) shares his Company's...

THTX : 1.3800 (+2.99%)
TH.TO : 1.89 (+2.16%)
Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Theratechnologies Inc.

/CNW/ - This press release is being disseminated as required by National Instrument 62–103 - The Early Warning System and Related Take Over Bids and Insider...

THTX : 1.3800 (+2.99%)
TH.TO : 1.89 (+2.16%)
Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Montreal, Quebec--(Newsfile Corp. - April 18, 2023) - Theratechnologies (NASDAQ: THTX) (TSX: TH), a biopharmaceutical company focused on the development and commercialization of innovative therapies,...

TH.TO : 1.89 (+2.16%)
THTX : 1.3800 (+2.99%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theratechnologies Inc. - THTX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Theratechnologies Inc. ("Theratechnologies" or the "Company") (NASDAQ: THTX)....

THTX : 1.3800 (+2.99%)
Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference

MONTREAL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical...

TH.TO : 1.89 (+2.16%)
THTX : 1.3800 (+2.99%)
Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens

New sub-analysis on Trogarzo clinical trial patients demonstrates that long-term viral suppression is not influenced by partially active agents. Predictive...

TH.TO : 1.89 (+2.16%)
THTX : 1.3800 (+2.99%)
Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form...

TH.TO : 1.89 (+2.16%)
THTX : 1.3800 (+2.99%)
Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update

– Q2 2022 Consolidated Sales Growth of 8.3% to $19.3 million – Year-to-Date Revenue Growth of 13.9% or $37.8 million – Year-to-Date EGRIFTA SV® Revenue...

TH.TO : 1.89 (+2.16%)
THTX : 1.3800 (+2.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is...

See More

Key Turning Points

3rd Resistance Point 1.4533
2nd Resistance Point 1.4167
1st Resistance Point 1.3983
Last Price 1.3800
1st Support Level 1.3433
2nd Support Level 1.3067
3rd Support Level 1.2883

See More

52-Week High 4.3000
Fibonacci 61.8% 2.9936
Fibonacci 50% 2.5900
Fibonacci 38.2% 2.1864
Last Price 1.3800
52-Week Low 0.8800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar